Editorial: Improving healthcare for incarcerated women

Journal of Women's Health

Volumn 19, Issue 1, 2010, Pages 13-15

  Springer, Sandra A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; PEGINTERFERON; RIBAVIRIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL ABUSE; CANCER SCREENING; COMMUNICABLE DISEASE; COMPARATIVE STUDY; DISEASE CONTROL; DRUG ABUSE; EDITORIAL; ETHNIC DIFFERENCE; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MENTAL DISEASE; PREVALENCE; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PRISONER; RACE DIFFERENCE; SECONDARY PREVENTION; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; TUBERCULOSIS; FEMALE; HEALTH CARE QUALITY; STANDARD; STATISTICS; UNITED STATES; WOMEN'S HEALTH;

FEMALE; HIV INFECTIONS; HUMANS; PRISONERS; QUALITY ASSURANCE, HEALTH CARE; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; WOMEN'S HEALTH;

EID: 75849133706     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1786     Document Type: Editorial

References (43)

1. Nijhawan AE, Salloway R, Nunn AS, Poshkus M, Clarke JG. Preventive healthcare for underserved women: Results of a prison survey. J Womens Health 2010;19:this issue.
2. Walmsley R. World prison population list. Kings College of London International. Centre for Prison Studies, London, 2008.
3. Harrison P, Karberg J. Prison and jail inmates at midyear 2003. In: Justice USDo, ed. Washington, DC: Bureau of Justice Statistics, 2004:1-14. 3a.
4. Sabol W, Couture H. Prison inmates at midyear 2007. Bureau of Justice Statistics. US Dept. of Justice, NCJ221944, 2008. 3b.
5. West HC, Sabol WJ. Prison inmates at midyear 2008- statistical tables. Bureau of Justice Statistics. US Dept. of Justice, NCJ225619, 2009. 3c.
6. Mumola C, Karberg J. Drug use and dependence, state and federal prisoners. US Dept. of Justice, Office of Justice Programs, Washington, DC, 2006. 3d.
7. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug Alcohol Depend 2009;105:83-88. Epub 2009, July 21. 3e.
8. The Pew Center on the States. One in 100: Behind Bars in America 2008. Washington, DC: The Pew Charitable Trusts, February, 2008. 3f.
9. Maruschak L, Beavers R. HIV in Prisons, 2007-2008. Bureau of Justice Statistics Bulletin, Washington, DC. US Dept. of Justice, Office of Justice Programs, 2009. http://bjs.ojp.usdoj .gov/index.cfm?ty=pbdetail&iid=1747. Accessed January 7, 2010.
10. Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: The revolving prison door. Am J Psychiatry 2009;166:103-109.
11. Peters RH, Greenbaum PE, Edens JF, Carter CR, Ortiz MM. Prevalence of DSM-IV substance abuse and dependence disorders among prison inmates. Am J Drug Alcohol Abuse 1998;24:573-587.
12. Reference deleted in proof.
13. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health 2002;92: 1789-1794.
14. Maru DS, Bruce RD, Basu S, Altice FL. Clinical outcomes of hepatitis C treatment in a prison setting: Feasibility and effectiveness for challenging treatment populations. Clin Infect Dis 2008;47:952-961.
15. Springer S, Friedland G, Doros G, Pesanti E, Altice FL. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. New Haven, CT: Yale AIDS Program, 2007.
16. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIVinfected prisoners: Reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis 2004; 38:1754-1760.
17. Altice FL, Khoshnood K, Blankenship KM, et al. Determinants of HIV seroprevalence and seroincidence of new entrants to a women's prison. Paper presented at XI International Conference on AIDS, Vancouver, Canada, 1996.
18. Altice FL, Marinovich A, Khoshnood K, Blankenship KM, Springer SA, Selwyn PA. Correlates of HIV infection among incarcerated women: Implications for improving detection of HIV infection. J Urban Health 2005;82:312-326.
19. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006. MMWR 2008;57:1073-1076.
20. Proca DM, Rofagha S, Keyhani-Rofagha S. High grade squamous intraepithelial lesion in inmates from Ohio: Cervical screening and biopsy follow-up. Cytojournal 2006;3:15.
21. Beck A, Karberg J, Harrison P. Prison and jail inmates at midyear 2001. In: U.S. Department of Justice, ed. Bureau of Justice Statistics Bulletin, 2002.
22. Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA 2009; 301:848-857.
23. Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep 2005;120:84-88.
24. Anderson RM, May RM. Epidemiological parameters of HIV transmission. Nature 1988;333:514-519.
25. Margolis AD, MacGowan RJ, Grinstead O, Sosman J, Kashif I, Flanigan TP. Unprotected sex with multiple partners: Implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis 2006;33:175-180.
26. Stephenson BL, Wohl DA, McKaig R, et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS 2006;17:103-108.
27. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55(RR-14):1-17.
28. Kinlock TW, Battjes RJ, Schwartz RP. A novel opioid maintenance program for prisoners: Preliminary findings. J Subst Abuse Treat 2002;22:141-147.
29. Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE. A study of methadone maintenance for male prisoners: 3-Month postrelease outcomes. Crim Justice Behav 2008;35:34-47.
30. Wexler HK, Lipton D, Johnson BA. A criminal justice system strategy for treating cocaine-heroin abusing offenders in custody. In: US Dept. of Justice, ed. Washington, DC, 1988.
31. Durand E. [Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996.] Ann Med Interne (Paris) 2001;152(Suppl 7):9-14.
32. Sibbald B. Methadone maintenance expands inside federal prisons. Can Med Assoc J 2002;167:1154.
33. Byrne A, Dolan K. Methadone treatment is widely accepted in prisons in New South Wales. BMJ 1998;316:1744-1745. (Pubitemid 28254440)
34. Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technol Assess 2007;11:1-171, iii-iv.
35. Garcia C, Correa G, Hernandez-Viver A, et al. Buprenorphinenaloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med 2007;1:126-132.
36. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2008:CD005031.
37. Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA 2009;301:183-190.
38. Smith-Rohrberg D, Bruce RD, Altice FL. Review of corrections-based therapy for opiate-depenndent patients: Implications for buprenorphine treatment among correctional populations. J Drug Issues 2004;34:451-480.
39. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA 2006;295:2003-2017.
40. Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep 2005;2:165-170.
41. Springer S, Altice F. Improving the care for HIV-infected prisoners: An integrated prison-release health model. In: Greifinger R, ed. Public health behind bars: From prisons to communities. New York: Springer Science, 2007.
42. Morrissey JP, Steadman HJ, Dalton KM, Cuellar A, Stiles P, Cuddeback GS. Medicaid enrollment and mental health service use following release of jail detainees with severe mental illness. Psychiatr Serv 2006;57:809-815.
43. Morrissey JP, Dalton KM, Steadman HJ, Cuddeback GS, Haynes D, Cuellar A. Assessing gaps between policy and practice in Medicaid disenrollment of jail detainees with severe mental illness. Psychiatr Serv 2006;57:803-808.